Capecitabine for hormone receptor‐positive versus hormone receptor‐negative breast cancer

BACKGROUND: Retrospective analyses suggest that capecitabine may carry superior activity in hormone receptor‐positive relative to hormone receptor‐negative metastatic breast cancer. This review examined the veracity of that finding and explored whether this differential activity extends to early bre...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cochrane Database Syst Rev
Huvudupphovsmän: Hoon, Siao-Nge, Lau, Peter K H, White, Alison M, Bulsara, Max K, Banks, Patricia D, Redfern, Andrew D
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Ltd 2021
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8150746/
https://ncbi.nlm.nih.gov/pubmed/34037241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011220.pub2
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk